Method of treating cancer with antineurotrophin agents

Details for Australian Patent Application No. 2001239913 (hide)

Owner Cephalon, Inc.

Inventors Miknyoczki, Sheila J.; Dionne, Craig A; Ruggeri, Bruce A.; Buchkovich, Karen J.

Agent Watermark

Pub. Number AU-B-2001239913

PCT Pub. Number WO01/64247

Priority 09793850 27.02.01 US; 60185943 29.02.00 US

Filing date 28 February 2001

Wipo publication date 12 September 2001

Acceptance publication date 8 December 2005

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 025/00 Drugs for disorders of the nervous system

A61K 031/7088 - Compounds having three or more nucleosides or nucleotides

C07K 014/71 Peptides having more than 20 amino acids

A61P 035/00 Antineoplastic agents

A61K 038/17 Medicinal preparations containing peptides - from animals

C07K 016/22 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

Event Publications

8 December 2005 Application Accepted

  Published as AU-B-2001239913

6 April 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001239914

2001239912